Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 118 institutions reported holding it in 13F filings for Q3 2026, worth $191.4M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Fennec Pharmaceuticals Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- +15 vs. Q2 2026
- Shares held
- 18.0M
- +1.66M (+10.2%) vs. Q2 2026
- Total value
- $191.4M
- +$16.4M (+9.4%) vs. Q2 2026
- New holders
- 22
- 37 more added
- Sold out
- 7
- 31 more reduced
2 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 118 | $191.4M |
| Q2 2026 | 105 | $175.1M |
| Q1 2026 | 91 | $99.6M |
| Q4 2025 | 96 | $119.6M |
| Q3 2025 | 84 | $129.8M |
| Q2 2025 | 78 | $112.9M |
| Q1 2025 | 68 | $81.6M |
| Q4 2024 | 64 | $101.4M |
| Q3 2024 | 63 | $74.6M |
| Q2 2024 | 64 | $87.7M |
| Q1 2024 | 65 | $161.1M |
| Q4 2023 | 56 | $168.4M |
| Q3 2023 | 55 | $107.6M |
| Q2 2023 | 56 | $124.5M |
| Q1 2023 | 54 | $108.5M |
| Q4 2022 | 43 | $119.5M |
| Q3 2022 | 31 | $92.1M |
| Q2 2022 | 28 | $63.2M |
| Q1 2022 | 28 | $64.1M |
| Q4 2021 | 30 | $49.9M |
| Q3 2021 | 32 | $109.7M |
| Q2 2021 | 39 | $88.0M |
| Q1 2021 | 53 | $89.3M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 178,039 | $1.90M | 0.00% | +117,707+195.1% | Added |
| Nuveen, LLC | 186,903 | $1.99M | 0.00% | +55,421+42.2% | Added |
| Los Angeles Capital Management LLC | 191,688 | $2.04M | 0.01% | +166,377+657.3% | Added |
| Vanguard Portfolio Management LLC | 203,055 | $2.16M | 0.00% | +3,057+1.5% | Added |
| Potomac Capital Management, Inc. | 224,500 | $2.39M | 1.91% | +1000.0% | Added |
| Qube Research & Technologies Ltd | 252,940 | $2.69M | 0.00% | +194,648+333.9% | Added |
| Morgan Stanley | 279,628 | $2.98M | 0.00% | +57,708+26.0% | Added |
| CenterBook Partners LP | 304,955 | $3.25M | 0.15% | +186,373+157.2% | Added |
| Essex Investment Management Co LLC | 318,771 | $3.39M | 0.50% | +318,771 | New |
| Geode Capital Management, LLC | 409,061 | $4.36M | 0.00% | +6,495+1.6% | Added |
| State Street Corp | 425,689 | $4.53M | 0.00% | −315−0.1% | Reduced |
| Vanguard Capital Management LLC | 839,306 | $8.94M | 0.00% | 00.0% | Unchanged |
| Prospect Capital Advisors, LLC | 886,600 | $9.44M | 4.66% | +388,800+78.1% | Added |
| AWM Investment Company, Inc. | 1,160,296 | $12.4M | 1.19% | 00.0% | Unchanged |
| Solas Capital Management, LLC | 1,433,282 | $15.3M | 8.52% | −456,084−24.1% | Reduced |
| BlackRock, Inc. | 2,033,398 | $21.7M | 0.00% | +306,329+17.7% | Added |
| AIGH Capital Management LLC | 2,499,421 | $26.6M | 3.02% | +13,383+0.5% | Added |
| Rosalind Advisors, Inc. | 3,188,001 | $34.0M | 10.98% | 00.0% | Unchanged |
| Cornerstone Capital, Inc. | 0 | $0 | 0.00% | −105,000−100.0% | Sold out |
| Eleva Capital SAS | 0 | $0 | 0.00% | −53,234−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −21,474−100.0% | Sold out |
| Kemnay Advisory Services Inc. | 0 | $0 | 0.00% | −12,586−100.0% | Sold out |
| Nano Cap New Millennium Growth Fund L P | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −141−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Royal Bank of Canada | – | – | – | – | Not filed |
| Core Capital Management & Research, inc. | – | – | – | – | Not filed |